Cefadroxil Dry Syrup

Beta Lactams · Dry Syrup / Oral Suspension · 125mg/5ml, 250mg/5ml

Trade Information

Minimum Order Qty	100,000 bottles
Capacity	5 Million Bottles per month
Strength	125mg/5ml, 250mg/5ml
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Dry syrup bottle (glass / PET)
Bottle with measuring cup
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Cefadroxil (as Cefadroxil Monohydrate)
Dosage Form	Dry Syrup / Oral Suspension
Pack Size	Bottle with measuring device (60ml / 100ml) / Custom packing available
Storage	Store below 25°C in a dry place, protected from light and moisture
Shelf Life	24 months from date of manufacture

Description

Cefadroxil is a first-generation cephalosporin distinguished by its longer duration of action, which allows convenient twice-daily dosing. It is widely used for skin and soft tissue infections and streptococcal pharyngitis.

BioGalen manufactures Cefadroxil as a paediatric dry syrup (125 mg/5 ml and 250 mg/5 ml on reconstitution). The twice-daily dosing supports treatment adherence in paediatric courses across the markets we serve.

Mechanism of Action

Cefadroxil is a first-generation cephalosporin that inhibits bacterial cell wall synthesis through binding to penicillin-binding proteins. It shares the Gram-positive strength of the first-generation class but has a longer plasma half-life than cephalexin, which supports twice-daily rather than more frequent dosing. This longer duration of action improves treatment adherence, a meaningful advantage in outpatient care.

Indications

Skin and soft tissue infections
Streptococcal pharyngitis and tonsillitis
Uncomplicated urinary tract infections
Other Gram-positive infections (as directed)

Available Variants

Cefadroxil Dry Syrup 125mg/5ml
Cefadroxil Dry Syrup 250mg/5ml

Frequently Asked Questions

How is Cefadroxil different from Cephalexin?

Both are first-generation cephalosporins with strong Gram-positive activity, but Cefadroxil has a longer half-life allowing twice-daily dosing, compared with the more frequent dosing of cephalexin, which can improve treatment adherence in outpatient settings.

What is Cefadroxil used for?

Cefadroxil is commonly used for skin and soft tissue infections and streptococcal pharyngitis, offering first-generation cephalosporin coverage with convenient twice-daily dosing.

What forms of Cefadroxil does BioGalen manufacture?

BioGalen manufactures Cefadroxil as a paediatric dry syrup (125 mg/5 ml and 250 mg/5 ml on reconstitution), under WHO-GMP with CTD and ACTD dossiers available.

Explore More

Interested in Cefadroxil Dry Syrup?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form